Skip to main content

Table 2 The serum levels of biomarkers

From: Associations of multiple serum biomarkers and the risk of cardiovascular disease in China

biomarkers

 

n

Min

25th

50th

75th

Max

P

TSH (mIU/L)

       

0.734

Case

161

0.16

1.36

1.98

2.83

21.99

 

Control

160

0.06

1.39

1.95

2.84

12.24

 

FT3 (pmol/L)

       

0.153

Case

161

2.27

4.51

4.99

5.46

7.04

 

Control

160

2.03

4.40

4.79

5.38

7.40

 

FT4 (pmol/L)

       

0.032

Case

161

6.30

15.99

17.92

19.43

23.72

 

Control

160

10.40

15.01

17.14

19.13

25.02

 

T3 (nmol/L)

       

0.976

Case

161

1.34

1.69

1.98

2.25

3.28

 

Control

160

1.28

1.76

1.98

2.20

2.96

 

T4 (nmol/L)

       

0.299

Case

161

49.08

90.66

105.50

118.50

165.30

 

Control

160

54.28

86.13

101.45

118.38

168.70

 

GLU (mmol/L)

       

< 0.001

Case

161

1.11

4.95

5.66

6.95

16.46

 

Control

160

3.95

4.74

5.10

5.75

14.31

 

CREA (μ mol/L)

       

0.299

Case

161

35.00

51.00

61.00

71.00

160.00

 

Control

160

32.00

52.00

60.50

69.00

621.00

 

UA (μ mol/L)

       

0.061

Case

161

45.00

235.50

276.00

328.50

573.00

 

Control

160

113.00

217.00

265.00

312.00

638.00

 

TC (mmol/L)

       

0.214

Case

161

2.31

4.27

4.98

5.57

7.67

 

Control

160

2.59

4.18

4.72

5.49

8.18

 

TG (mmol/L)

       

< 0.001

Case

161

0.54

1.15

1.61

2.19

9.14

 

Control

160

0.34

0.87

1.27

1.72

7.76

 

HDL-c (mmol/L)

       

0.018

Case

161

0.50

0.92

1.06

1.26

2.13

 

Control

160

0.50

0.98

1.11

1.32

1.91

 

LDL-c (mmol/L)

       

0.013

Case

161

1.32

2.48

2.89

3.41

6.44

 

Control

160

0.97

2.30

2.70

3.15

5.23

 

HCY (μ mol/L)

       

0.693

Case

161

5.50

9.35

11.10

13.50

44.50

 

Control

160

4.60

9.60

11.20

13.78

60.70